Combining cashew gum with cyclophosphamide in murine melanoma model: A strategy for the reduction of side effects

Ayslan Batista Barros,Felipe Barros Teles,Dakson Douglas Araújo,Durcilene Alves Da Silva,Luma Brisa Pereira Dos Santos,Nayze Lucena Sangreman Aldeman,Aurilene Gomes Cajado,Alexia Nathália Brígido Assef,Diego Veras Wilke,Roberto Cesar Pereira Lima-Junior,Ana Jérsia Araújo,José Delano Barreto Marinho-Filho

DOI: https://doi.org/10.1016/j.ijbiomac.2024.133588

Abstract:The understanding of cancer immunity and antitumor factors generated by natural polysaccharides is not yet fully comprehended. Polysaccharides, like cashew gum (CG), can exhibit immunomodulatory action and may assist in the antitumor process and side effects relieve. This study aimed to determine the antitumor effect of CG alone or in combination with cyclophosphamide (CTX), and its interactions with immune cells, in a murine melanoma model, using the B16-F10 cell line. Tumor growth inhibition, hematological, histopathological, ELISA, flow cytometry, immunofluorescence, and qRT-PCR analyses were performed to elucidate the antitumor potential, involvement of immune cells, and potential toxic effects. CG showed significant tumor growth inhibition, reaching up to 42.9 % alone and 51.4 % in combination with CTX, with mild toxicity to organs. CG enhanced leukocyte count, even in the presence of CTX. Furthermore, CG influenced the activation of tumor-associated macrophages (TAM), characterized by an increase in Il4, as well as a reduction in Ifng, Il1b, Tgfb, and Il6 gene expression. Nevertheless, these effects did not compromise the antitumor activity of CG. In summary, the combination of CG with CTX is a promising approach for leukopenia, one of the most important side effects of cancer treatment and deserves further investigation.